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The use of Cre-driver rodent lines for targeting
ventral tegmental area (VTA) cell types has generated
important and novel insights into how precise neuro-
circuits regulate physiology and behavior. While
this approach generally results in enhanced cellular
specificity, an important issue has recently emerged
related to the selectivity and penetrance of viral tar-
geting of VTA neurons using several Cre-driver trans-
genic mouse lines. Here, we highlight several consid-
erations when utilizing these tools to study the
function of genetically defined neurocircuits. While
VTA dopaminergic neurons have previously been tar-
geted and defined by the expression of single genes
important for aspects of dopamine neurotransmis-
sion, many VTA and neighboring cells display dy-
namic gene expression phenotypes that are partially
consistent with both classically described dopami-
nergic and non-dopaminergic neurons. Thus, in
addition to varying degrees of selectivity and pene-
trance, distinct Cre lines likely permit targeting
of partially overlapping, but not identical VTA cell
populations. This Matters Arising Response paper
addresses the Lammel et al. (2015) Matters Arising
paper, published concurrently in Neuron.
INTRODUCTION
Accurately defining and studying the function of distinct neural
subtypes and circuits represents one of the major challenges in
neuroscience today. Cell types can be defined by a variety of
means such as anatomical location, afferent and efferent connec-
tivity, electrophysiological properties, and behavioral functions,
or by their molecular characteristic such as their gene expression
profiles. Given the intense heterogeneity of nervous system tis-
sue, many recent studies have utilized genetic tools, such as ro-
dent lines, that express Cre-recombinase under selected gene
promoters (Gerfen et al., 2013; Taniguchi et al., 2011; Witten
et al., 2011) in order to selectively monitor or manipulate neuronal
subpopulations. Furthermore, genetically defined neurons that
express Cre-recombinase can reliably be targeted for optoge-netic or chemogenetic manipulation in anatomically defined brain
regions in adult animals by utilizing cre-inducible viral constructs
(Atasoy et al., 2008; Sohal et al., 2009) that are stereotaxically
delivered to the brain region of interest. Overall, this combined
approach has generated tremendous insight into the organiza-
tion and function of genetically defined neural circuits. These
tools have widely been adopted and are now commonly used
throughout many distinct subfields of neuroscience. Below we
discuss some important aspects related to the use of these ap-
proaches within the context of the ventral tegmental area (VTA),
a heterogeneous brain region critical for motivated behavior.
The VTA contains many distinct cell types, the two classically
described populations being dopaminergic and GABAergic neu-
rons that are largely intermixed. A smaller population of VTA glu-
tamatergic neurons has also been identified (Yamaguchi et al.,
2007, 2011). VTA dopaminergic neurons have been targeted
for manipulation by utilizingmouse lines that express Cre recom-
binase under the control of gene promoters thought to define a
dopaminergic phenotype. The two most commonly used lines
drive expression under the tyrosine hydroxylase promoter (TH-
Cre; Lindeberg et al., 2004; Savitt et al., 2005) or the dopamine
transporter promoter (DAT-Cre; Ba¨ckman et al., 2006; Zhuang
et al., 2005). While these are excellent genetic tools to gain
further insight into VTA circuits, the presence of a single gene,
such as TH or DAT alone within a neuron, contributes to, but
does not solely define, its phenotype. Consistent with this, dopa-
minergic neurons have previously been shown to be quite het-
erogeneous with respect to their projection targets, gene
expression profiles, and physiological properties (Lammel
et al., 2008; Margolis et al., 2006, 2008).
Lammel et al. (2015) report that TH-Cre or TH-GFP mouse
lines display ectopic targeting of non-dopaminergic VTA neu-
rons. Below we highlight important conceptual and technical ca-
veats for the use of Cre driver lines to target VTA circuitry. In
addition, we discuss the idea that individual neurons are more
accurately described by a phenotypic spectrum as opposed to
a digital classification system, especially when defining cell pop-
ulations based on the expression patterns of single genes. This is
largely based on evidence that individual VTA cells can co-ex-
press genes or immunostain for markers associated with the
biosynthesis of multiple neurotransmitters, and that the expres-
sion levels of TH and DAT can vary dramatically across individual
VTA neurons or animal strain, suggesting that TH-Cre and DAT-
Cre transgenic mouse lines label partially overlapping, but not
identical, midbrain cell populations.Neuron 85, 439–445, January 21, 2015 ª2015 Elsevier Inc. 439
Figure 1. Differences in TH Immunofluore-
sence Intensity across the Medial-Lateral
VTA Axis
(A) Confocal image of medial TH+ neurons with
optimal gain.
(B) Confocal image of lateral TH+ neurons with gain
optimized for the medial portion. Note that most
neurons are oversaturated.
(C) Confocal image of medial VTA TH+ neurons
with gain optimized for lateral VTA TH+ neurons.
Note that neurons that were previously visible
(A, white arrows) are now difficult to discern.
(D) Confocal image of lateral TH+ neurons with gain
optimized for lateral portion.RESULTS AND DISCUSSION
Lammel et al. (2015), in this issue of Neuron, report that many
midbrain cells targeted in TH-Cre or TH-GFP lines are not TH
positive and that targeted neurons are located outside of the
VTA/SNc. They conclude that appreciable ectopic expression
exists in these TH-driven transgenic lines, but not in the DAT-
cre mouse line that was also tested. In addition, they conclude
that VTA neurons that project to the lateral habenula (LHb) are
largely GABAergic. Based on the data and conclusions pre-
sented in their paper, there are three points that we think merit
further discussion.
(1) Selectivity and Penetrance of Transgene Expression
in TH-Cre Lines and DAT-Cre Mouse Lines
Lammel et al. (2015) report that following Cre-inducible virus
injection into the VTA of TH-Cre or DAT-Cre mice, there is appre-
ciable viral-mediated expression in both TH-positive and TH-
negative neurons in and around the VTA in the TH-Cre line, while
viral expression is restricted to VTA TH-positive neurons in the
DAT-Cre line. In addition, in the lateral VTA there is high co-local-
ization between TH and targeted neurons in the TH-Cre line, but
co-localization is significantly less in the medial VTA in this line.
These results may be due to ectopic cre expression in themedial
VTA in the TH-Cre lines (cre expression in cells that are TH nega-
tive) or due to sufficient cre expression in neurons only weakly440 Neuron 85, 439–445, January 21, 2015 ª2015 Elsevier Inc.expressing TH mRNA or protein. Consis-
tent with the latter, TH expression and
immunofluorescence can vary widely
from cell to cell and along the medial-
lateral axis (Harris and Nestler, 1996;
Weiss-Wunder and Chesselet, 1991; Fig-
ure 1), and thus it is possible that immuno-
fluorescent staining may not reliably label
neurons that produce low levels of TH
protein. This may be less of an issue
with the DAT-Cre mouse line since DAT
is enriched in cells that also express high
levels of TH (Lammel et al., 2008; Stama-
takis et al., 2013). It is important to
note that Cre-mediated recombination
can likely occur in cells with even weakly
active promoters, and thus low levels ofCre, since virally mediated Cre-inducible transgene expression
is decoupled from the levels of expression at the endogenous
genetic locus (Atasoy et al., 2008; Sohal et al., 2009). Moreover,
it is unclear whether viral titer or injection volume may also influ-
ence targeted cell selectivity since Cre-inducible expression
systems likely depend not only on the amount of Cre present in
a cell, but also on the number of virally delivered transgenes
that undergo recombination. Therefore, the discrepancy be-
tween the percentage of overlap between eYFP+ and TH+ neu-
rons reported in Lammel et al. (2015) and previous studies
(Chaudhury et al., 2013; Stamatakis et al., 2013; Tsai et al.,
2009; Tye et al., 2013) could be due to differences in immunohis-
tochemical techniques and confocal imaging parameters in
addition to the quantification of particular VTA subregions as
they discussed.
In wild-type animals TH-positive neurons are also distributed
in areas surrounding the VTA/SNc including the retrorubral field
and periaquaductal gray (Nair-Roberts et al., 2008) and, to a
lesser extent, the substantia nigra pars reticulata (Stork et al.,
1994). In fact, the A10 dopaminergic cell group has been previ-
ously described to contain a dense extension of TH-positive
neurons that reside in the tuberomamillary nucleus and the
medial supramammiliary region (Swanson, 1982). Therefore, it
is not particularly surprising that Lammel et al. (2015) report
the presence eYFP+ neurons in areas surrounding the VTA in
the TH-Cre line, especially considering the large volumes of virus
injected in their study. In contrast, DAT expression is largely
restricted to TH-positive neurons in VTA/Sn but does not co-
localize completely with TH-positive neurons in the VTA (Blan-
chard et al., 1995; Li et al., 2013). Thus, it is likely that DAT-Cre
and TH-Cre mouse lines permit targeting of overlapping, but
not identical, populations of VTA neurons. The TH-Cre lines
thus may display reduced selectivity for dopaminergic neurons
(as defined by expressing high levels of both TH and DAT pro-
tein), especially in the medial VTA compared to the DAT-Cre
line as reported by Lammel et al. (2015). However, the DAT-
Cre line may have reduced penetrance for targeting dopami-
nergic neurons compared to the TH-Cre lines as non-striatal
projecting TH+ VTA cells display reduced levels of DAT
compared to nucleus accumbens projecting cells (Lammel
et al., 2008). Both selectivity and penetrance of transgene
expression are important factors to consider and should be eval-
uated collectively based on the purpose of the experiment.
(2) Cellular Phenotype of LHb-Projecting VTA Neurons
In the manuscript by Lammel et al. (2015), they report that LHb-
projecting VTA neurons are GABAergic or glutamatergic, and
that these LHb projections act to inhibit or excite LHb postsyn-
aptic neurons, respectively, which in turn promotes reward or
aversive-related behavior. These results are consistent with our
previous work (Stamatakis et al., 2013) as well the work of others
(Hnasko et al., 2012; Root et al., 2014a, 2014b). Moreover, in our
previous paper (Stamatakis et al., 2013) we reported that viral
targeting of VTA neurons in the TH-Cre line resulted in labeled fi-
bers in the LHb that release GABA to inhibit LHb neurons to pro-
mote reward. In addition, retrograde labeling of LHb-projecting
VTA neurons in mice and rats demonstrates that this projection
arises from a mixture of TH-positive and TH-negative VTA neu-
rons (Gruber et al., 2007; Skagerberg et al., 1984; Stamatakis
et al., 2013; Swanson, 1982). Additionally, in situ hybridization
experiments revealed that over 20% of LHb-projecting VTA neu-
rons co-express TH,GAD, and VGlut2 (Root et al., 2014b). Thus,
LHb-projecting VTA neurons are genetically diverse and express
markers consistent with multiple neurotransmitter systems,
which likely regulates the functionality of this circuit.
We have previously referred to LHb-projecting VTA neurons
as having a hybrid phenotype, which is consistent with gene
expression data from these cells (Root et al., 2014b). However,
as we previously demonstrated (and was confirmed by Lammel
et al.) the targeted VTA-to-LHb projection in the TH-Cre line is
largely functionally GABAergic and acts to inhibit LHb neurons.
Interestingly, while Lammel et al. (2015) did not observe signifi-
cant eYFP fibers in the LHb from the DAT-Cremice, we observed
appreciable eYFP fibers in this line following virus injection in
the VTA (Figure 2). We also observed a qualitatively different
expression pattern from Vgat-Cre mice (Figure 2). Collectively,
these data (as well as work by Morales and colleagues [Morales
and Root, 2014; Root et al., 2014a, 2014b]) demonstrate that
LHb-projecting VTA neurons are genetically heterogeneous
and cannot be simply classified as strictly dopaminergic,
GABAergic, or glutamatergic based on single genetic markers
as proposed by Lammel et al. Instead, we argue that the most
accurate description of VTA neurons that project to the LHb
would be a mixture of both functional GABAergic and glutama-tergic neurons, some of which also express genetic markers
for dopaminergic neurons. This assessment is based on experi-
ments conducted in both wild-type and transgenic animals and
is not dependent on any single Cre driver line.
(3) Electrophysiological Properties of LHb-Projecting
VTA Neurons
Lammel et al. (2015) recorded from eYFP+/TH+ and eYFP+/TH
VTA neurons in the TH-Cre line (which may have low to no TH
expression and protein, as discussed above) and report that
eYFP+/TH neurons have electrophysiological characteristics
thataresimilar toGABAergicneuronsand thus thesecellsare likely
ectopically labeled GABAergic neurons and not dopaminergic
neurons. However, the electrophysiological phenotype of these
neurons is also consistent with medial dopaminergic neurons
that show electrophysiological properties similar to GABAergic
neurons. Indeed, Lammel and colleagues have previously re-
ported that cortical-projecting dopaminergic neurons, which are
enriched in the medial VTA, show elevated basal firing rates and
narrow action potentials, lack functional D2 autoreceptors, and
lacks a hyperpolarization-activated inwardly rectifying cation cur-
rent (Lammel et al., 2008). Thus the electrophysiological pheno-
typesofVTAneuronsmaybemore related to their projection target
and locationwithin theVTA, thanwhether they immunostain forTH.
Co-localization and Heterogeneity of Dopaminergic,
Glutamatergic, and GABAergic Cell Markers within VTA
Neurons: Implications for Utilizing Single-Gene Cre
Driver Lines to Study Neurocircuitry
As discussed above, some VTA neurons express markers
consistent with the synthesis and release of multiple small mole-
cule neurotransmitters. For example, up to 20% of VTA TH-pos-
itive neurons also express the gene coding for the vesicular
glutamate transporter 2 (VGLUT2), a marker for putative gluta-
matergic neurons (Hnasko et al., 2010, 2012; Kawano et al.,
2006; Li et al., 2013; Mendez et al., 2008; Root et al., 2014b; Ya-
maguchi et al., 2011). Consistent with this, optical stimulation of
dopaminergic fibers that innervate striatal subregions results in
the release of dopamine, glutamate, and GABA (Stuber et al.,
2010; Tecuapetla et al., 2010; Tritsch et al., 2012). Thus, there
is evidence in the literature that previously defined midbrain
dopaminergic neurons can express genes and display physio-
logical properties that are consistent with multiple modalities of
neurotransmission. Furthermore, there is emerging evidence
that some individual midbrain neurons may express dopami-
nergic and GABAergic gene markers (Root et al., 2014b). In the
lateral VTA and substantia nigra pars compacta (SNc), TH-ex-
pressing neurons and those that express GABA synthetic en-
zymes (GAD65 and GAD67) are almost completely segregated
(Nair-Roberts et al., 2008; Tritsch et al., 2014; Figure 3). Howev-
er, in the anterior medial VTA and surrounding areas including
the tuberomamillary nucleus, TH or DAT and GAD are co-ex-
pressed in a number of cells (Olson and Nestler, 2007; Root
et al., 2014b; Tritsch et al., 2014; Figure 3). Finally, a recent study
has demonstrated that the majority of LHb-projecting VTA neu-
rons, some of which express TH, release both glutamate and
GABA (Root et al., 2014b). Collectively, these emerging findings
suggest that single gene markers such as TH, DAT, VGLUT2, or
GAD65/67 cannot fully define the molecular phenotype of VTANeuron 85, 439–445, January 21, 2015 ª2015 Elsevier Inc. 441
Figure 2. DAT-Cre, TH-Cre, and VGat-Cre Targeted Neurons Project to the LHb
Confocal image of a coronal LHb section (1.7 posterior) showing expression of ChR2-eYFP fibers in the LHb following injection of cre-inducible ChR2-eYFP into
the VTA of a DAT-Cre mouse (A), TH-Cre mouse (B), and VGat-Cre mouse (C). Scale bar = 200 mm.neuronal subpopulations. This is especially important to
consider when targeting VTA circuitry with a rodent line that ex-
presses Cre under the control of a single gene promoter.
ADDITIONAL CONSIDERATIONS AND FUTURE
DIRECTIONS
Accurately defining and manipulating exact cellular phenotypes
in the nervous system requires comprehensive information on
the connectivity, physiological function, anatomical location,
and genetic landscape of numerous individual neurons sampled
from a larger population. Applying automated and non-biased
cluster analysis approaches to these integrated but diverse
data setsmay uncover more specific cellular phenotypes. Future
studies that implement these approaches promise to provide a442 Neuron 85, 439–445, January 21, 2015 ª2015 Elsevier Inc.more accurate definition of the cellular diversity within the VTA
and other brain structures, and also permit for the implementa-
tion of intersectional genetic approaches (Dymecki et al., 2010;
Robertson et al., 2013) for targeted manipulation of cell types
based on combinatorial gene expression patterns (Fenno et al.,
2014). Finally, it is important to consider that neuronal pheno-
types are likely dynamically regulated and not static. Develop-
mental, environmental, activity-dependent, and epigenetic
regulation likely produce pronounced alterations in neuronal
phenotypes and neurocircuit function (Andersson et al., 2006;
Dulcis et al., 2013; Go´mez-Lira et al., 2005; Guemez-Gamboa
et al., 2014; Matsushita et al., 2002; Stott et al., 2013; Telese
et al., 2013). Genetically informed neuronal targeting strategies
continue to generate new insights. Corroborating these findings
with a multifaceted approach will provide a more holistic
Figure 3. Dual Fluorescent In Situ Hybridization for TH and GAD67 in the VTA
(A and B) Confocal image of the anterior medial VTA (2.8 posterior) from a wild-type mouse showing appreciable colocalization between THmRNA (green) and
GAD67 mRNA (red). Overlap = 32/191 neurons (16.7%). Scale bar (A) = 200 mm. Scale bar (B) = 50 mm.
(C and D) Confocal image of the posterior lateral VTA (3.2 posterior) from a wild-type mouse showing minimal colocalization between TH mRNA and GAD67
mRNA. Overlap = 1/263 neurons (0.38%). Scale bar (C) = 200 mm. Scale bar (D) = 50 mm.understand ding of the functional cellular architecture of the
nervous system.
EXPERIMENTAL PROCEDURES
Methods were adapted as previously described (Stamatakis et al., 2013).
Briefly, Vgat-ires-Cre (Slc32a1tm2(cre)Lowl/J, Jackson Laboratory stock
number: 016962), Dat-ires-Cre (B6.SJL-Slc6a3tm1.1(cre)Bkmn/J, Jackson
Laboratory stock number: 006660), and TH-ires-Cre: (B6.129X1- Thtm1(cre)
Te/Kieg, European Mouse Mutant Archive stock number: EM:00254) were
used. Mice were injected bilaterally with AAV-DIO-ChR2-eYFP (AAV5 1012
infectious units/mL, packaged and titered by the UNC Vector Core Facility).
Immunohistochemistry
Mice were anesthetized with pentobarbital and transcardially perfused
with PBS followed by 4% (w/v) paraformaldehyde in PBS. Brains were then
removed and submerged for 24 hr in 4% paraformaldehyde and transferred
to 30% sucrose in ddH2O for 48 hr. Brain slices of 40 mm were obtained
and subjected to immunohistochemical staining for neuronal cell bodies
(NeuroTrace Invitrogen; 435-nm excitation/455-nm emission), and/or tyrosine
hydoylase (Pel Freeze; made in sheep, 1:500). Brain sections were mounted,
and z-stack and tiled images were captured on a Zeiss LSM 710 confocal
microscope using a 203 or 633 objective. For fluorescent intensity analysis,
images were acquired using identical pinhole, gain, and laser settings for all
brain regions.
In Situ Hybridization
A 950 bp riboprobe complimentary to GAD67 sense cDNA was inserted into
the pcrII-TOPO vector (Life Technologies, Carlsbad, CA). Plasmid DNA wascut with either EcoRV or Asp718 in order to create template for in vitro tran-
scription. All probes were created using Fluorescein-labeled nucleotides.
The EcoRV template was transcribed with Sp6 RNA Polymerase to generate
the sense riboprobe and the Asp718 template was transcribed with T7 RNA
polymerase to generate the antisense riboprobe. For detection of TH
expression, we used a 1,000-bp riboprobe complimentary to tyrosine
hydroxylase sense cDNA that was inserted into the pGEM-4Z vector (Prom-
ega, Madison, WI). Plasmid DNA was cut with either EcoRI or HindIII in order
to create template for in vitro transcription. All probes were created using
DIG-labeled nucleotides. The HindIII template was transcribed with Sp6
RNA Polymerase to generate the sense riboprobe and the EcoRI template
was transcribed with T7 RNA polymerase to generate the antisense
riboprobe.
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